作者：
M F,Mosele [1]
;
C B,Westphalen [2]
;
A,Stenzinger [3]
;
F,Barlesi [4]
;
A,Bayle [5]
;
I,Bièche [6]
;
J,Bonastre [7]
;
E,Castro [8]
;
R,Dienstmann [9]
;
A,Krämer [10]
;
A M,Czarnecka [11]
;
F,Meric-Bernstam [12]
;
S,Michiels [7]
;
R,Miller [13]
;
N,Normanno [14]
;
J,Reis-Filho [15]
;
J,Remon [16]
;
M,Robson [17]
;
E,Rouleau [18]
;
A,Scarpa [19]
;
C,Serrano [20]
;
J,Mateo [20]
;
F,André [21]
作者单位：
INSERM U981, Gustave Roussy, Villejuif; Department of Cancer Medicine, Gustave Roussy, Villejuif, France.
[1]
Comprehensive Cancer Center Munich & Department of Medicine III, University Hospital, LMU Munich, Munich.
[2]
Institute of Pathology, University Hospital Heidelberg and Center for Personalized Medicine (ZPM), Heidelberg, Germany.
[3]
INSERM U981, Gustave Roussy, Villejuif; Department of Cancer Medicine, Gustave Roussy, Villejuif, France; Faculty of Medicine, Université Paris-Saclay, Kremlin Bicêtre.
[4]
Faculty of Medicine, Université Paris-Saclay, Kremlin Bicêtre; Drug Development Department (DITEP), Gustave Roussy, Villejuif; Oncostat U1018, Inserm, Université Paris-Saclay, labeled Ligue Contre le Cancer, Villejuif; Service de Biostatistique et Epidémiologie, Gustave Roussy, Villejuif.
[5]
Department of Genetics, Institut Curie, INSERM U1016, Université Paris Cité, Paris, France.
[6]
Oncostat U1018, Inserm, Université Paris-Saclay, labeled Ligue Contre le Cancer, Villejuif; Service de Biostatistique et Epidémiologie, Gustave Roussy, Villejuif.
[7]
Department of Medical Oncology, Hospital Universitario 12 de Octubre, Instituto de Investigación Sanitaria Hospital 12 de Octubre, Madrid.
[8]
Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron Barcelona Hospital Campus, Barcelona; University of Vic-Central University of Catalonia, Vic, Spain; Oncoclínicas, São Paulo, Brazil.
[9]
Clinical Cooperation Unit Molecular Hematology/Oncology, German Cancer Research Center (DKFZ), Heidelberg; Department of Internal Medicine V, University of Heidelberg, Heidelberg, Germany.
[10]
Department of Soft Tissue/Bone Sarcoma and Melanoma, Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw; Department of Experimental Pharmacology, Mossakowski Medical Research Centre, Polish Academy of Sciences, Warsaw, Poland.
[11]
Department of Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, USA.
[12]
Department of Medical Oncology, University College London, London; Department of Medical Oncology, St Bartholomew's Hospital, London, UK.
[13]
Scientific Directorate, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) "Dino Amadori", Meldola, Italy.
[14]
Department of Pathology, Memorial Sloan Kettering Cancer Center, New York.
[15]
Department of Cancer Medicine, Gustave Roussy, Villejuif, France.
[16]
Breast Medicine and Clinical Genetics Services, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, USA.
[17]
Tumor Genetics Service, Medical Biology and Pathology Department, Gustave Roussy, Villejuif, France.
[18]
Section of Pathology, Department of Diagnostics and Public Health, University of Verona-School of Medicine, Verona, Italy.
[19]
Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron Barcelona Hospital Campus, Barcelona.
[20]
INSERM U981, Gustave Roussy, Villejuif; Department of Cancer Medicine, Gustave Roussy, Villejuif, France; Faculty of Medicine, Université Paris-Saclay, Kremlin Bicêtre. Electronic address: education@esmo.org.
[21]
DOI
10.1016/j.annonc.2024.04.005
PMID
38834388
发布时间
2024-06-23
换一批
换一批
